CellMax Life Revenue and Competitors

Location

$14M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CellMax Life's estimated annual revenue is currently $2.9M per year.(i)
  • CellMax Life received $9.0M in venture funding in July 2016.
  • CellMax Life's estimated revenue per employee is $77,500
  • CellMax Life's total funding is $14M.

Employee Data

  • CellMax Life has 37 Employees.(i)
  • CellMax Life grew their employee count by -24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax's unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$14M

Total Funding

37

Number of Employees

$2.9M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CellMax Life's People

NameTitleEmail/Phone
1
Accounting and Operation ManagerReveal Email/Phone
2
Product ManagerReveal Email/Phone
3
Co-Founder. R&D DirectorReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Manger BioinformaticsReveal Email/Phone
6
NGS Assay DevelopmentReveal Email/Phone
7
ctDNA Assay DevelopmentReveal Email/Phone
8
BioinformaticsReveal Email/Phone
9
Advisor & CollaboratorReveal Email/Phone
10
Advisor & CollaboratorReveal Email/Phone

CellMax Life News

2022-04-20 - Lung Cancer Liquid Biops Market Size, Outlook And Forecast ...

... Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience, Cancer Genetics, CellMax Life.

2022-04-19 - Global Tumor Fluid Biopsy Market 2022 Emerging Trend and ...

Cellmax Life; Burning Rock Biotech; Berry Genomics Co; HaploX Biotechnology Co; New Horizon Health Limited; Genetronhealth; Amoy Diagnostics Co...

2019-09-08 - Anatomic Pathology Market Value Trend 2019 Estimated Size ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

2019-09-03 - CellMax Life blood test study detects precancer colorectal ...

A study by CellMax Life found that the company's blood-based test was able to detect the small, precancerous colon polyps known as ...

2019-09-03 - Anatomic Pathology Market 2019 Size, Share, Future ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M370%N/A
#2
$4.3M37-34%N/A
#3
$3M3712%N/A
#4
$3M38-3%N/A
#5
$9.5M3852%N/A

CellMax Life Funding

DateAmountRoundLead InvestorsReference
2016-07-27$9.0MA-1Artiman VenturesArticle